David L. Boone

5.2k total citations · 3 hit papers
35 papers, 4.2k citations indexed

About

David L. Boone is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, David L. Boone has authored 35 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 10 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in David L. Boone's work include Immune Cell Function and Interaction (16 papers), T-cell and B-cell Immunology (13 papers) and IL-33, ST2, and ILC Pathways (7 papers). David L. Boone is often cited by papers focused on Immune Cell Function and Interaction (16 papers), T-cell and B-cell Immunology (13 papers) and IL-33, ST2, and ILC Pathways (7 papers). David L. Boone collaborates with scholars based in United States, Chile and Ireland. David L. Boone's co-authors include Averil Ma, Sophia Chai, James P. Lodolce, Marcia Chien, Patrick R. Burkett, Themistocles Dassopoulos, Rima Koka, E. John Wherry, Todd C. Becker and Rafi Ahmed and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

David L. Boone

34 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-15 Receptor Maintains Lymphoid Homeostasis by Supporting Lymphocyte Homing and Proliferation

1998 1.1k citations James P. Lodolce, David L. Boone et al. Immunity profile →
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses

2004 889 citations David L. Boone, Emre E. Turer et al. Nature Immunology profile →
Interleukin 15 Is Required for Proliferative Renewal of Virus-specific Memory CD8 T Cells

2002 572 citations Todd C. Becker, E. John Wherry et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David L. Boone United States	19	3.5k	762	746	579	576	35	4.2k
James P. Lodolce United States	14	2.4k 0.7×	784 1.0×	545 0.7×	391 0.7×	727 1.3×	20	3.1k
Marcia Chien United States	11	2.4k 0.7×	1.1k 1.4×	520 0.7×	341 0.6×	1.1k 1.8×	16	3.3k
Clair M. Gardiner Ireland	34	3.6k 1.0×	560 0.7×	601 0.8×	433 0.7×	434 0.8×	59	4.3k
Sophia Chai United States	12	3.6k 1.0×	1.5k 1.9×	770 1.0×	475 0.8×	1.2k 2.0×	16	4.9k
Satoru Kumaki Japan	25	3.5k 1.0×	606 0.8×	1.1k 1.4×	566 1.0×	221 0.4×	74	4.3k
Beichu Guo United States	22	2.4k 0.7×	1.2k 1.5×	639 0.9×	381 0.7×	685 1.2×	28	3.4k
Kurt Shanebeck Canada	16	3.4k 1.0×	650 0.9×	834 1.1×	644 1.1×	178 0.3×	21	4.3k
Shinsuke Taki Japan	28	2.7k 0.8×	800 1.0×	916 1.2×	227 0.4×	282 0.5×	64	3.5k
Viktor Steimle Switzerland	31	3.4k 1.0×	1.3k 1.7×	847 1.1×	323 0.6×	344 0.6×	45	4.4k
Reiko Shinkura Japan	29	1.9k 0.6×	1.3k 1.7×	416 0.6×	344 0.6×	438 0.8×	48	3.1k

Countries citing papers authored by David L. Boone

Since Specialization

Citations

This map shows the geographic impact of David L. Boone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Boone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Boone more than expected).

Fields of papers citing papers by David L. Boone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Boone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Boone. The network helps show where David L. Boone may publish in the future.

Co-authorship network of co-authors of David L. Boone

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Boone. A scholar is included among the top collaborators of David L. Boone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Boone. David L. Boone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Booth, Laurence, Michael R. Booth, Jane L. Roberts, et al.. (2025). The SCD1 inhibitor aramchol interacts with regorafenib to kill GI tumor cells in vitro and in vivo. Oncotarget. 16(1). 662–678.

Mayer, L, et al.. (2024). Retinoid orphan receptor gamma t (rorγt) promotes inflammatory eosinophilia but is dispensable for innate immune-mediated colitis. PLoS ONE. 19(3). e0300892–e0300892. 1 indexed citations

Boone, David L., et al.. (2022). TNFAIP3 DRIVES COLITIS THROUGH DEATH CELL AND TNFα PRODUCTION. Gastroenterology. 162(3). S61–S61. 1 indexed citations

Grayson, Bernadette E., et al.. (2021). Gastrokine-1, an anti-amyloidogenic protein secreted by the stomach, regulates diet-induced obesity. Scientific Reports. 11(1). 9477–9477. 7 indexed citations

Garcia‐Carbonell, Ricard, Jerry Wong, Ju Youn Kim, et al.. (2018). Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell death. Proceedings of the National Academy of Sciences. 115(39). E9192–E9200. 75 indexed citations

Abernathy‐Close, Lisa, et al.. (2018). The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis. Mucosal Immunology. 11(5). 1454–1465. 10 indexed citations

Grimm, Wesley A., Jeannette S. Messer, Stephen F. Murphy, et al.. (2015). The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon. Gut. 65(3). 456–464. 71 indexed citations

Chen, Peili, et al.. (2015). Antrum Mucosal Protein-18 Peptide Targets Tight Junctions to Protect and Heal Barrier Structure and Function in Models of Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 21(10). 1–1. 20 indexed citations

Murphy, Stephen F., Lesley Rhee, Wesley A. Grimm, et al.. (2014). Intestinal epithelial expression of TNFAIP3 results in microbial invasion of the inner mucus layer and induces colitis in IL-10-deficient mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 307(9). G871–G882. 17 indexed citations

10.

Lodolce, James P., Lesley Rhee, Silvia N. Kariuki, et al.. (2010). African-Derived Genetic Polymorphisms in TNFAIP3 Mediate Risk for Autoimmunity. The Journal of Immunology. 184(12). 7001–7009. 77 indexed citations

11.

Burkett, Patrick R., Rima Koka, Marcia Chien, et al.. (2004). Coordinate Expression and Trans Presentation of Interleukin (IL)-15Rα and IL-15 Supports Natural Killer Cell and Memory CD8+ T Cell Homeostasis. The Journal of Experimental Medicine. 200(7). 825–834. 313 indexed citations

12.

Boone, David L., Emre E. Turer, Rizwan Ahmad, et al.. (2004). The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nature Immunology. 5(10). 1052–1060. 889 indexed citations breakdown →

13.

Boone, David L. & Averil Ma. (2003). Connecting the dots from Toll-like receptors to innate immune cells and inflammatory bowel disease. Journal of Clinical Investigation. 111(9). 1284–1286. 1 indexed citations

14.

Koka, Rima, Patrick R. Burkett, Marcia Chien, et al.. (2003). Interleukin (IL)-15Rα–deficient Natural Killer Cells Survive in Normal but Not IL-15Rα–deficient Mice. The Journal of Experimental Medicine. 197(8). 977–984. 208 indexed citations

15.

Boone, David L., Themistocles Dassopoulos, Sophia Chai, et al.. (2003). Fas is not essential for lamina propria T lymphocyte homeostasis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 285(2). G382–G388. 3 indexed citations

16.

Becker, Todd C., E. John Wherry, David L. Boone, et al.. (2002). Interleukin 15 Is Required for Proliferative Renewal of Virus-specific Memory CD8 T Cells. The Journal of Experimental Medicine. 195(12). 1541–1548. 572 indexed citations breakdown →

17.

Lodolce, James P., Patrick R. Burkett, Rima Koka, David L. Boone, & Averil Ma. (2002). Regulation of lymphoid homeostasis by interleukin-15. Cytokine & Growth Factor Reviews. 13(6). 429–439. 88 indexed citations

18.

Boone, David L., Themistocles Dassopoulos, James P. Lodolce, et al.. (2002). Interleukin-2-Deficient Mice Develop Colitis in the Absence of CD28 Costimulation. Inflammatory Bowel Diseases. 8(1). 35–42. 10 indexed citations

19.

Hawrylak, Nicholas, David L. Boone, & A.K. Salm. (1999). The surface density of glial fibrillary acidic protein immunopositive astrocytic processes in the rat supraoptic nucleus is reversibly altered by dehydration and rehydration. Neuroscience Letters. 277(1). 57–60. 18 indexed citations

20.

Lodolce, James P., et al.. (1998). IL-15 Receptor Maintains Lymphoid Homeostasis by Supporting Lymphocyte Homing and Proliferation. Immunity. 9(5). 669–676. 1076 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact